Mode
Text Size
Log in / Sign up
N/A N=254 Randomized Other

Innovative Approaches for Minor Consent: Consent 2.0

HIV

Enrolled (actual)
254
Serious AEs
0.0%
Results posted
Apr 2021
Primary outcome: Primary: Mean Adolescent WTP Scores — 3.7; 3.7; 3.5 score on a scale — p=0.5148

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Autonomous minor consent (Other); Adult permission required (Other); Parental permission required (Other)
Age
Pediatric · 14+ yrs
Sex
All
Sponsor
Indiana University
Primary completion
Sep 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Mean Adolescent WTP Scores
3.7; 3.7; 3.5 0.5148
PRIMARY
Mean Parent WTS Scores
2.6; 3.1; 4.4 <.0001 sig
PRIMARY
Effects of the Study Agent (Stage of Development and Method of Delivery) on High-risk Minor Adolescents' WTP Scores
3.6; 3.7; 3.6; 3.8; 3.8; 3.4 0.4324
PRIMARY
Effects of the Study Agent (Stage of Development and Method of Delivery) on Parents' Acceptability Scores
2.7; 3.1; 4.3; 2.6; 3.1; 4.4 <.0001 sig

Summary

The purpose of this study is to examine how the consent process affects the acceptability of participation in biomedical HIV prevention trials, from the perspective of behaviorally high-risk minors and the parents of minor adolescents.

Eligibility Criteria

Note: Age limits apply to adolescent participants and to the adolescent children of parent participants.

Adolescent Inclusion Criteria

  • Age 14-17 inclusive
  • Able to read and speak English
  • HIV status is negative or unknown
  • Engaged in high-risk sexual activity in the last six months

Adolescent Exclusion Criteria

  • Child of a parent already enrolled in the study

Parent Inclusion Criteria

  • Able to read and speak English
  • Parent or guardian of an adolescent who is between ages 14-17
  • The parent/guardian's adolescent's HIV status is either negative or unknown

Parent Exclusion Criteria

  • Parent of a child already enrolled in the study
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03242954). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search